Aptorum Group Limited (NASDAQ: APM)
$4.14
-0.3900 ( -8.61% ) 51.7K
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
Market Data
Open
$4.14
Previous close
$4.53
Volume
51.7K
Market cap
$23.58M
Day range
$4.14 - $4.60
52 week range
$1.35 - $17.49
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Aug 10, 2023 |
6-k/a | Quarterly Reports | 1 | Jul 14, 2023 |